These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. US radiation report fails to satisfy critics. Macilwain C Nature; 1995 Oct; 377(6549):470. PubMed ID: 7566133 [No Abstract] [Full Text] [Related]
23. Proposed requirements for informed consent go beyond current federal regulations. Hum Res Rep; 1994 Jul; 9(7):1-3. PubMed ID: 11659879 [No Abstract] [Full Text] [Related]
24. Are research subjects adequately protected? A review and discussion of studies conducted by the Advisory Committee on Human Radiation Experiments. Kass NE; Sugarman J Kennedy Inst Ethics J; 1996 Sep; 6(3):271-82. PubMed ID: 11653398 [TBL] [Abstract][Full Text] [Related]
25. Federal agency keeps review committee after public comments support continuation. Maloney DM Hum Res Rep; 1997 Jan; 12(1):1-2. PubMed ID: 11654603 [No Abstract] [Full Text] [Related]
26. Judging the past. The case of the human radiation experiments. Buchanan A Hastings Cent Rep; 1996; 26(3):25-30. PubMed ID: 8736672 [No Abstract] [Full Text] [Related]
27. Clinton names 15 to advisory panel on ethics in human experimentation. Weiss R Washington Post; 1996 Jul; ():A9. PubMed ID: 11648024 [No Abstract] [Full Text] [Related]
28. The controversy over retrospective moral judgment. Buchanan A Kennedy Inst Ethics J; 1996 Sep; 6(3):245-50. PubMed ID: 11653396 [TBL] [Abstract][Full Text] [Related]
29. Department of Health and Human Services, Public Health Service, National Institutes of Health. Recombinant DNA Advisory Committee, Points to Consider Subcommittee. Minutes of meeting, March 31, 1989. Recomb DNA Tech Bull; 1989 Sep; 12(3):151-70. PubMed ID: 2595016 [No Abstract] [Full Text] [Related]
31. Beyond localism: a proposal for a National Research Review Board. Levine C; Caplan AL IRB; 1986; 8(2):7-9. PubMed ID: 11649751 [No Abstract] [Full Text] [Related]
32. IRBs and pharmaceutical company funding of research. Jellinek MS; Levine RJ IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693 [No Abstract] [Full Text] [Related]
33. Radiation and responsibility. Feinberg KR Washington Post; 1995 Oct; ():A23. PubMed ID: 11647088 [No Abstract] [Full Text] [Related]
34. Special informed consent requirements are included in protocol review procedures. Maloney DM Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274 [No Abstract] [Full Text] [Related]
36. A word to Varmus. Pryor D; Hatfield M; Wyden R; Waxman HA Hastings Cent Rep; 1996; 26(4):46-7. PubMed ID: 11644858 [No Abstract] [Full Text] [Related]
37. Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials. Gordon VM; Sugarman J; Kass N IRB; 1998; 20(1):1-5. PubMed ID: 11655324 [No Abstract] [Full Text] [Related]
38. Universal protection for all human research participants. Maloney DM Hum Res Rep; 2001 Jul; 16(7):1-2. PubMed ID: 11933953 [No Abstract] [Full Text] [Related]
39. The institutional review board and beyond: future challenges to the ethics of human experimentation. Edgar H; Rothman DJ Milbank Q; 1995; 73(4):489-506. PubMed ID: 7491097 [TBL] [Abstract][Full Text] [Related]
40. Health Research Extension Act of 1985. Public Law 99-158. United States US Statut Large; 1985; 99(Title IV Sections 1-12):. PubMed ID: 11686169 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]